Clinical History (3 of 3)
As it entered the 1960s, National Jewish, was a 60-year-old TB
hospital, enthusiastically starting a new mission. By then, TB patients
comprised only half of the patient population and asthma patients a
third. Most of the remainder were cardiac surgery patients. During the
early 60s, the hospital treated a wide range of other lung diseases,
including emphysema, chronic bronchitis and cystic fibrosis. And it
treated more cases of bronchiectasis, silicosis, sarcoidosis and fungus
infections of the lungs.
As the hospital continued to extend its reach, it began creating new
clinical programs and developing innovative medical technology. It
developed a pediatric facility called the Children’s Treatment Center
allowing it to meet the needs of an increasing pediatric asthma
population. And in keeping with important developments in both TB and
asthma, the physicians wanted to expand the institution’s emphasis on
clinical immunology. It soon began building a strong clinical
immunology team in 1969.
That same year, a fee-for-service policy was established based on a
patient's ability to pay. But the spirit of the hospital's motto since
its inception, "None may enter who can pay-none can pay who enter," was
still observed.
During the next couple of decades, the hospital’s emphasis on
research continued to grow and it helped identify numerous new
treatment options for respiratory and immunologic diseases.
In 1978 the National Asthma Center (NAC) in Denver began to succumb
to financial struggles and proposed a merger with National Jewish. The
two consolidated in September of that year and with the merger came a
blending of the two pediatric asthma services making National Jewish
the world’s largest treatment center for pediatric and adult asthma.
A Shift to Outpatient Care
During the 1990s, National Jewish shifted its focus from inpatient
care to more cost effective outpatient visits. To that point, in 1995,
the hospital officially launched a day-treatment program in pediatrics
which allowed for intensive treatment of children during the day but
offered the advantage of nights at home, or in a hotel, with their
parents. By early 1996, an adult day-treatment program also was
introduced.
To accelerate the move to outpatient care, partnerships were forged
with other healthcare providers, including The Children’s Hospital and
University of Colorado Hospital. Under these mutually beneficial
agreements, National Jewish patients who required hospital care were
admitted at partner institutions. National Jewish also opened a number
of off-site clinics throughout the state of Colorado.
By the late 1990s and entering the new millennium, National Jewish
began to widen its reach even further as it drew upon its decades-long
expertise in treating respiratory diseases to establish a
Disease-Specific Care Management (DSCM) service for asthma and COPD.
Nurses took calls over a toll-free line and provided guidance to
patients, doctors, HMOs and other healthcare professionals. In the
following years, National Jewish developed other national
telephone-based services, including Quitline, a smoking cessation
program, and FitLogix™, a weight management program. These programs
also boast online components. In the past 5 years, these programs have
helped over 350,000 people who face the two most common behaviorally
related causes of death in the United States.
Decade of Innovation
In 2007 the board approved a new strategic plan which called
attention to personalized healthcare as an emerging trend, enabled by
technology, knowledge of genetics and biology, economics and
consumerism. Personalized medicine presented opportunities to enable
healthcare practices to be increasingly patient-specific by taking into
account individual differences in health states, disease processes and
outcomes from interventions. This new goal of proactive, preventive,
individualized medicine required a more complete research continuum to
further integrate clinical care with translational and basic science
research at the point of the patient.
In addition, a continued emphasis on research and education of the
next generation of leaders in medicine and science would ensure that
National Jewish remain preeminent in its areas of focus.
Page 1, 2, 3
Read about National Jewish Health's history in research.
Read about National Jewish Health's academic history.